Katarzyna Kaczyńska Selected Research

Katarzyna Kaczyńska Research Topics

Disease

7	Asthma (Bronchial Asthma) 12/2021 - 01/2018
5	Hypoxia (Hypoxemia) 05/2022 - 03/2017
4	Inflammation (Inflammations) 12/2021 - 10/2016
4	Apnea 11/2020 - 01/2006
3	Respiratory Insufficiency (Respiratory Failure) 12/2021 - 03/2010
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 03/2017
3	Hypotension (Low Blood Pressure) 10/2020 - 09/2007
2	Obstructive Sleep Apnea 01/2021 - 01/2018
2	Bradycardia 10/2020 - 12/2015
1	Alzheimer Disease (Alzheimer's Disease) 05/2022
1	Hypercapnia 05/2022
1	Cognitive Dysfunction 05/2022
1	Respiratory Hypersensitivity 01/2021
1	Lung Diseases (Lung Disease) 07/2020
1	Neoplasms (Cancer) 02/2019
1	Occupational Asthma 12/2018
1	Hypersensitivity (Allergy) 10/2016
1	Contact Dermatitis (Eczema, Contact) 10/2016
1	Body Weight (Weight, Body) 12/2013
1	Fibrosis (Cirrhosis) 12/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013
1	Infections 01/2012
1	Tachycardia (Tachyarrhythmias) 01/2011
1	Hypertension (High Blood Pressure) 01/2011
1	Hypoventilation 03/2010
1	Hyperventilation 08/2002

Drug/Important Bio-Agent (IBA)

5	NeurotensinIBA 12/2021 - 10/2016
5	HaptensIBA 07/2020 - 10/2016
4	Peptides (Polypeptides)IBA 12/2021 - 10/2016
4	Opioid Analgesics (Opioids)IBA 12/2021 - 10/2016
3	Opioid Receptors (Opioid Receptor)IBA 11/2020 - 02/2017
3	endomorphin 2IBA 10/2020 - 10/2016
3	DinitrofluorobenzeneIBA 07/2020 - 10/2016
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2022 - 01/2006
2	CytokinesIBA 01/2021 - 07/2020
2	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 03/2017
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 07/2017
2	Oxidopamine (6 Hydroxydopamine)IBA 03/2020 - 07/2017
1	AcetylcholinesteraseIBA 05/2022
1	Rivastigmine (Exelon)FDA LinkGeneric 05/2022
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 05/2022
1	Memantine (Namenda)FDA Link 05/2022
1	Neuropeptide YIBA 12/2021
1	TachykininsIBA 12/2021
1	Peptide Receptors (Peptide Receptor)IBA 12/2021
1	DefensinsIBA 12/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2021
1	Biogenic Amines (Biogenic Amine)IBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Phospholipases (Phospholipase)IBA 01/2021
1	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021
1	Reserpine (Serpasil)FDA Link 01/2021
1	Malondialdehyde (Propanedial)IBA 01/2021
1	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 11/2020
1	SolutionsIBA 07/2020
1	Interleukin-6 (Interleukin 6)IBA 07/2020
1	SaltsIBA 07/2020
1	brineIBA 07/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2019
1	sulforaphaneIBA 02/2019
1	NeuropeptidesIBA 01/2018
1	5-HT2 Serotonin ReceptorsIBA 03/2017
1	neurotensin (8-13)IBA 10/2016
1	Sincalide FDA Link 12/2015
1	Retinaldehyde (Retinal)IBA 12/2013
1	sodium iodateIBA 12/2013
1	CollagenIBA 12/2013
1	ElastinIBA 12/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2012
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2011
1	Phentolamine (Z-Max)FDA LinkGeneric 01/2011
1	BombesinIBA 01/2011
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2010
1	1- (2- methoxyphenyl)- 4- (4- (2- phthalimido)butyl)piperazineIBA 09/2007
1	N-Methylaspartate (NMDA)IBA 01/2006
1	2-amino-7-phosphonoheptanoic acidIBA 01/2006
1	gamma-Aminobutyric Acid (GABA)IBA 08/2002

Therapy/Procedure

5	Therapeutics 12/2021 - 01/2012
2	Vagotomy 03/2010 - 01/2006
1	Analgesia 11/2020
1	Intravenous Administration 02/2017
1	Intravitreal Injections 12/2013